In the CMA response to the Government’s de-regulation agenda, we recommended the TGA streamline the evaluation of new substances for use as permitted ingredients for listed medicines.
We have been working to put forward a list of potential new substances that may be subject to an expedited evaluation or risk assessment, including potential substances approved by Health Canada or where substances have been subject to previous TGA review.

Click here to read the alert and to provide feedback.